A Center for a Livable Future study, published recently in Environmental Science and Technology, shows that testing of imported seafood by the U.S. Food and Drug Administration (FDA) is inadequate for confirming its safety or identifying risks.
About 85 percent of seafood consumed in the U.S. is imported, and most of those imports are produced in overseas fish farms, where drugs may be administered to the fish to treat and prevent fish diseases. In terms of food safety, imported seafood is one of the most significant high-risk foods, and FDA oversees the safety of imports. CLF researchers David Love, PhD, and colleagues believed it was important to measure and evaluate the degree to which imported seafood is tested for drug residues. Read More >